The FDA Public Affairs director, Erica V. Jefferson, stated that, they are “working with several state health departments and the Massachusetts Board of Pharmacy on this issue and is still investigating the scope and cause of the outbreak of fungal meningitis.” On September 26th the New England Compounding Center voluntarily recalled three lots of Methylprednisolone (PF) 80mg/ml Injection produced at the Center. The lot numbers included in the recall are:
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@68
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #06292012@26
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #08102012@51
The New England Compounding Center has stated that it is, “working closely with the Massachusetts Department of Public Health and other regulators to identify the source of infection.” The Center immediately recalled the product as soon as they were notified about the contaminated medicine.